Effect of Reduction of Inflammatory Status on Glucose Metabolism in Overweight Men
NCT00221052
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Overweight
Obesity
Inflammation
Interventions
DRUG:
Diclofenac
Sponsor
TNO